Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory Pathways
Genes · 25.04.2025 · 16 (5) · 487
DOI: 10.3390/genes16050487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 25.04.2025. Verfasst von Jelena Milic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Public Health of Serbia "Dr Milan Jovanovic Batut", Dr. Subotica Starijeg 6, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Biomarkers, Epigenesis, Genetic, Depression, Depressive Disorder. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Introduction
Depression is a pervasive global health issue, affecting millions worldwide and causing significant disability. Despite its prevalence, current diagnostic and treatment approaches often yield suboptimal outcomes. The complexity of depression, characterized by diverse causes and symptoms, highlights the urgent need for advanced diagnostic tools and personalized therapies. Biomarkers, particularly genetic and epigenetic depression biomarkers, offer promise in uncovering the biological mechanisms underlying depression, potentially revolutionizing its management.
Aim
Primary aim: To identify biomarkers associated with depressive disorders, with a focus on genetic and epigenetic biomarkers. Secondary aim: To optimize the current classification of biomarkers associated with different types of depressive disorders, with a focus on genetic and epigenetic biomarkers.
Methods
We integrated findings with strategic keywords extracted from relevant studies, conducting a thorough literature review across the Google Scholar, PubMed, and Web of Science databases. Lastly, final reference inclusion had stringent criteria: recent, diverse peer-reviewed articles in English, all study designs, ensuring up-to-date coverage of genetic and epigenetic depression biomarker research.
Results
The review reveals the classification of genetic and epigenetic biomarkers in regard to the type of biomarker, the system of the human body it derives from, and the sampling entity. All of the findings show promise in diagnosing depression, with the potential of predicting treatment outcomes and guiding personalized therapeutic approaches. We defined the significant correlations between genetic and epigenetic biomarker profiles and clinical parameters such as symptom severity and treatment response, thereby enhancing diagnostic accuracy and guiding treatment strategies tailored to individual patient needs across diverse depressive subtypes and treatment responses.
Conclusion
Identifying biomarkers associated with depressive disorders, with a focus on genetic and epigenetic biomarkers, represents a critical step toward improving diagnostic precision and treatment efficacy. By elucidating the complex biological underpinnings of depression, this study contributes to the development of targeted therapies that address the diverse needs of individuals affected by this debilitating group of disorders. Future research should focus on validating these genetic and epigenetic biomarkers in larger cohorts and clinical trials to facilitate their clinical implementation and enhance patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Public Health of Serbia "Dr Milan Jovanovic Batut", Dr. Subotica Starijeg 6, 11000 Belgrade, Serbia.
- Faculty of Nursing, Serbia European University KALLOS, Gospodara Vucica 40, 11000 Belgrade, Serbia.
- Faculty of Security Studies, University of Belgrade, Gospodara Vucica 40, 11000 Belgrade, Serbia.
- Faculty of Health Studies, University of Bijeljina, 76300 Bijeljina, Republika Srpska, Bosnia and Herzegovina.
ORCID-Profile: Jelena Milic, Rosa Sapic
Zitieren
APA
Milic, J., Jovic, S., & Sapic, R. (2025). Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory Pathways. Genes, 16(5), 487. https://doi.org/10.3390/genes16050487
Vancouver
Milic J, Jovic S, Sapic R. Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory Pathways. Genes. 2025;16(5):487. doi:10.3390/genes16050487
BibTeX
@article{Milic2025,
author = {Milic, Jelena and Jovic, Sladjana and Sapic, Rosa},
title = {Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory Pathways},
journal = {Genes},
year = {2025},
volume = {16},
number = {5},
pages = {487},
doi = {10.3390/genes16050487}
}
EUVIMED